标题:
1.Pharmacokinetics of a Single 150-mg Intravenous Infusion of Fosaprepitant: Effects of Concentration and Infusion Time in Healthy Japanese Men
作者:Azuma, Junichi 1;Fukase, Hiroyuki 2 刊名:Clinical Pharmacology in Drug Development 出版日期:2013 期号:No.4 卷号:Vol.2
2.Pharmacokinetic evaluation of fosaprepitant dimeglumine 作者:Colon-Gonzalez F;Kraft WK. 刊名:Expert Opinion on Drug Metabolism and Toxicology 出版日期:2010 期号:No.10 卷号:Vol.6
3.Pharmacokinetics of Oral Dexamethasone and Midazolam When Administered With Single-Dose Intravenous 150 mg Fosaprepitant in Healthy Adult Subjects 作者:Dr Thomas C. Marbury MD1,*;Ms Phung L. Ngo MS2;Mr Craig R. Shadle MS2;Dr Bo Jin PhD2;Ms Deborah Panebianco MS2;Dr Luzelena Caro PhD2;Dr Jack Valentine PhD2,3;Dr Gail Murphy MD2 刊名:J Clin Pharmacol 出版日期:2011 卷号:Vol.51
4.A Single-Dose Bioequivalence and Food Effect Study With Aprepitant and Fosaprepitant Dimeglumine in Healthy Young Adult Subjects 作者:Craig R. Shadle1,*;M. Gail Murphy1;Yang Liu2;Maureen Ho1;Daniel Tatosian3;Susie (Xiujiang) Li3;Robert A. Blum4 刊名:Clinical Pharmacology in Drug Development 出版日期:2012 期号:No.3 卷号:Vol.1
5.Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy 作者:Bernardo Rapoport;Teresa Smit 刊名:Expert Opinion on Drug Safety
6.Aprepitant and Fosaprepitant Drug Interactions: A Systematic Review. 作者:Patel P;Leeder JS;Piquette-Miller M;Dupuis LL. 刊名:Br J Clin Pharmacol 出版日期:2017
7.Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects. 作者:Dr Kenneth C. Lasseter MD1,*;Dr Jay Gambale PharmD2;Dr Bo Jin PhD2;Dr Art Bergman PhD2;Mr Marvin Constanzer MS2;Mr James Dru MS2;Dr Tae H. Han PhD2;Dr Anup Majumdar PhD2;Dr Judith K. Evans MD2;Dr M. Gail Murphy MD2 刊名:The Journal of Clinical Pharmacology 出版日期:2007 期号:NO.7 卷号:Vol.47
8.Prevention of chemotherapy-induced nausea and vomiting:focus on fosaprepitant 作者:Ian N Olver 刊名:Ther Clin Risk Manag 出版日期:2008 期号:No.2 卷号:Vol.4
[更多]